Luthringer Remy's Insider Trades & SAST Disclosures
Luthringer Remy's most recent trade in Minerva Neurosciences Inc was a trade of 105,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 5, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Luthringer Remy.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Minerva Neurosciences Inc | Luthringer Remy | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 105,000 | 105,000 | - | - | Employee Stock Option (right to buy) | |
| Minerva Neurosciences Inc | Remy Luthringer | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 88,077 | 96,388 (0%) | 0% | 0 | Common Stock | |
| Minerva Neurosciences Inc | Remy Luthringer | Director, CEO | Sale of securities on an exchange or to another person at price $ 3.85 per share. | 28 Apr 2023 | 23,753 | 72,635 (0%) | 0% | 3.8 | 91,449 | Common Stock |
| Minerva Neurosciences Inc | Remy Luthringer | Director, CEO | Sale of securities on an exchange or to another person at price $ 3.76 per share. | 28 Apr 2023 | 3,641 | 68,994 (0%) | 0% | 3.8 | 13,690 | Common Stock |
| Minerva Neurosciences Inc | Remy Luthringer | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 45,000 | 45,000 | - | - | Employee Stock Option (right to buy) | |
| Minerva Neurosciences Inc | Remy Luthringer | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 505,000 | 505,000 | - | - | Employee Stock Option (right to buy) | |
| Minerva Neurosciences Inc | Remy Luthringer | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2020 | 18,750 | 0 | - | - | Restricted Stock Unit | |
| Minerva Neurosciences Inc | Remy Luthringer | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2020 | 18,750 | 67,790 (0%) | 0% | - | Common Stock | |
| Minerva Neurosciences Inc | Remy Luthringer | Director, CEO | Sale of securities on an exchange or to another person at price $ 2.64 per share. | 14 Dec 2020 | 1,300 | 66,490 (0%) | 0% | 2.6 | 3,432 | Common Stock |
| Minerva Neurosciences Inc | Remy Luthringer | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2020 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
| Minerva Neurosciences Inc | Remy Luthringer | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2020 | 354,302 | 354,302 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges